Cargando…
Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study
This multicenter retrospective study aimed to clarify the prognostic factors for mortality and changes in treatment modalities and disease activities after the onset of Pneumocystis jirovecii pneumonia (PCP) in patients with rheumatoid arthritis (RA). Data regarding the clinical background, treatmen...
Autores principales: | Shiba, Hideyuki, Kotani, Takuya, Nagai, Koji, Hata, Kenichiro, Yamamoto, Wataru, Yoshikawa, Ayaka, Wada, Yumiko, Hiramatsu, Yuri, Makino, Hidehiko, Ueda, Yo, Onishi, Akira, Murata, Koichi, Amuro, Hideki, Son, Yonsu, Hara, Ryota, Hirano, Toru, Ebina, Kosuke, Katayama, Masaki, Hashimoto, Motomu, Takeuchi, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138913/ https://www.ncbi.nlm.nih.gov/pubmed/37108561 http://dx.doi.org/10.3390/ijms24087399 |
Ejemplares similares
-
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
por: Ebina, Kosuke, et al.
Publicado: (2020) -
Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-
por: Ebina, Kosuke, et al.
Publicado: (2019) -
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study
por: Jinno, Sadao, et al.
Publicado: (2021) -
Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study
por: Ebina, Kosuke, et al.
Publicado: (2019) -
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
por: Ebina, Kosuke, et al.
Publicado: (2022)